Result of AGM

/**/

RNS Number : 3303N Iconic Labs PLC 31 December 2025  

31 December 2025 Iconic Labs Plc ("Iconic" or the "Company") Result of AGM The Directors of Iconic Labs Plc are pleased to announce that at the Annual General Meeting of the Company held earlier today, Resolutions 1 to 7 were all were duly approved by shareholders by way of a poll. The results of the poll were as follows:   



Resolutions

For

%

Against

%

Withheld

1

To receive and adopt the accounts for the financial year ended 30 June 2025.

1,714,575

99.35%

11,176

0.65%

8,985

2

To re-appoint RPG Chartered Accountants as Auditors.

1,712,111

99.21%

13,640

0.79%

8,985

3

To authorise the Directors to determine the remuneration of the Auditors.

1,710,100

99.21%

13,640

0.79%

10,996

4

To re-appoint Bela Lendvai-Lintner as a Director.

1,680,380

97.45%

43,887

2.55%

10,469

5

To authorise the Directors to allot shares as set out in the Notice of the meeting.

1,680,974

97.56%

42,054

2.44%

11,708



Special Resolutions:









6

To adopt new Articles of Association

1,686,150

97.82%

37,640

2.18%

10,946

7

To empower the Directors to generally allot relevant equity securities as set out in the Notice of the meeting.

1,681,376

97.57%

41,887

2.43%

11,473

  ENDS For more information, please contact:

Iconic Labs   John Farquharson, Chief Executive Officer  

via Yellow Jersey PR

AlbR Capital Limited Daniel Harris / David Coffman

Tel: +44 (0) 20 7469 0930  

Yellow Jersey PR Charles Goodwin Annabelle Wills    

Tel: +44 (0) 20 3004 9512 iconic@yellowjerseypr.com  

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.  END  RAGWPGQWPUPAGGG